Generated by AI
InterCure Ltd. is an Israel-based pharmaceutical cannabis company focused on the production, manufacturing, and distribution of medical cannabis products. Through its subsidiaries, it develops and supplies pharmaceutical-grade dried cannabis inflorescences and cannabis extracts for medical use in Israel and international markets. The company also operates in the broader biomed sector, reflecting a business mix that combines cannabis operations with investments in healthcare-related portfolio companies. InterCure serves patients, healthcare providers, and distribution partners through a vertically integrated model that spans research, cultivation, production, and delivery of cannabis-based therapies. Headquartered in Herzliya, Israel, InterCure plays a significant role in the regulated medical cannabis market by emphasizing clinical-grade standards and licensed production capabilities.
Website85 Medinat ha-Yehudim Street
Herzliya, 4676670
Israel
The latest articles about INCR.
Detailed price information for Intercure Ltd (INCR-Q) from The Globe and Mail including charting and trades.
NEW YORK and HERZLIYA, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InterCure Ltd. (Nasdaq: INCR) (TASE: INCR) (“InterCure” or the “Company”) anno...
InterCure (INCR) said Tuesday it has regained compliance with Nasdaq's minimum bid price listing rul
Detailed price information for Intercure Ltd (INCR-Q) from The Globe and Mail including charting and trades.
Summary of Aug 24's posts. Generated by AI.
Summary of Sep 3's posts. Generated by AI.
Summary of Aug 24's posts. Generated by AI.
Investors talking about INCR also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.